Stay updated on Pembrolizumab in RCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T21:40:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-13T04:39:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-05T20:51:35.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now loads a 403 Forbidden error instead of the expected study record, indicating that access to the page is blocked. The view shows the 403 message along with the site's header and footer, reflecting an access restriction rather than a modification to the study data.
    Difference
    18%
    Check dated 2026-09-21T22:28:14.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added, replacing the previous v3.6.5. This reflects an update to the page's revision metadata rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-31T16:36:57.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study's identifiers section includes a new line documenting an NIH grant/contract (2016). This addition records funding information as part of the study's administrative identifiers.
    Difference
    0.1%
    Check dated 2026-08-24T16:17:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.